$5.66
Today
as of Jul 22, 16:51 ET
Last 30 days
Recent Press Releases & News
Myriad Genetics Launches FirstGene® Multiple Prenatal Screen
AWHL vs. MYGN: Which Women's Health Diagnostics Stock is Better Now?
Is This the Right Time to Hold MYGN Stock in Your Portfolio?
Overview
52-week range
$3.53
$8.59
42% of range
Avg surprise (last 3)
+21.0%
Avg reaction (last 2)
-1.9%
50% positive
Latest IV / EM
97%
EM ±22.1% · $6 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue May 5, 2026 | Mar/2026 | $-0.16 | $-0.16 | 0.0% | -14.3% | +1.8% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.29 | — | — | — | — | financials |
| Tue Aug 5, 2025 | Jun/2025 | $-0.06 | $-0.11 | +45.5% | — | — | earnings |
| Tue May 6, 2025 | Mar/2025 | $-0.14 | $-0.17 | +17.6% | — | -5.6% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.24 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.41 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.29 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.75 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-1.42 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Tue Aug 4, 2026 | Jun/2026 | OTHER | -$0.08 | -$0.06 | -33.3% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | $138M | — | $144M | $152M | $134M | — | $150M | $147M |
| Operating income | $-31M | — | $-23M | $-329M | $-29M | — | $-20M | $-36M |
| Net income | $-34M | — | $-27M | $-330M | $-100,000 | — | $-22M | $-37M |
| EPS (diluted) | $-0.36 | — | $-0.29 | $-3.57 | — | — | $-0.24 | $-0.41 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $124M | $150M | $145M | $74M | $92M | $102M | $100M | $92M |
| Inventory | $28M | $31M | $32M | $29M | $28M | $28M | $26M | $26M |
| Total current assets | $313M | $333M | $345M | $284M | $287M | $298M | $293M | $292M |
| Total assets | $674M | $707M | $728M | $677M | $1.01B | $1.03B | $1.08B | $1.09B |
| Long-term debt | $120M | $120M | $120M | $0 | $59M | $40M | $39M | $39M |
| Total liabilities | $336M | $339M | $355M | $289M | $301M | $326M | $350M | $345M |
| Total equity | $337M | $368M | $373M | $388M | $705M | $701M | $732M | $740M |